About Us Resources Catalysts Start Free Trial →

Loading…

Day Trader Sniper provides algorithmic alerts and analysis, not trade advice.
Not financial advice. Trade at your own risk.

Quick Links

Download The App Resources Market Feed Stocks

Catalysts About Us Support Privacy policy Terms of use

©2026 Day Trader Sniper - all rights reserved

Home›Catalysts›Corporate Deals

Catalyst Category

Corporate Deals

Live feed of every catalyst classified under Corporate Deals.

CATALYSTS IN FEED

228

AVG MAX MOVE

+113.7%

POSITIVE MOVES

100%

LARGEST MOVE

+1877.0%

Acquisition Closed Announce Business Combination Approve Transaction By Shareholders Asset Deal Announced Asset Purchase Deal Asset Sale Closed Closing Timeline Update Collaboration Deal Collaboration Deal Signed Deal Closed Deal Terminated Equity Investment Exclusive License Granted Joint Venture Announced Joint Venture Formed Joint Venture Funding Joint Venture Live License Agreement Signed LOI/MOU Announced Merger Announced Merger Deal Closed Merger Update Ownership Stake Increased Settlement Agreement Spinoff Announced Strategic Investment Deal Upfront Payment Deal

Range–

Showing 4 of 228

Corporate DealsFeb 19, 2025 · 6:16pm ET

KYNBKYNTRA BIO, INC.

FibroGen Sells China Subsidiary to AstraZeneca for Approximately $160 Million

Transaction includes $85 million enterprise value and $75 million net cash held in China.

Be first on the next Corporate Deals catalyst.

Day Trader Sniper alerts you the instant a setup like this triggers.

Download Free →

Max move

+79.3%

RVOL

9.9x

Max high

$26.00

Fuel

23m

Corporate DealsFeb 19, 2025 · 6:16pm ET

KYNBKYNTRA BIO, INC.+79.3%

FibroGen Sells China Subsidiary to AstraZeneca for Approximately $160 Million

RVOL

9.9x

Max high

$26.00

Fuel

23m

Corporate DealsFeb 5, 2025 · 7:58pm ET

RLMDRelmada Therapeutics, Inc. Common Stock

Relmada Therapeutics Acquires Sepranolone from Asarina Pharma

The acquisition includes a Phase 2b ready neurosteroid.

Corporate DealsFeb 5, 2025 · 7:58pm ET

RLMDRelmada Therapeutics, Inc. Common Stock+56.8%

Relmada Therapeutics Acquires Sepranolone from Asarina Pharma

Corporate DealsFeb 4, 2025 · 6:59pm ET

IVVDInvivyd, Inc.

Invivyd Partners with Jim Harbaugh to Highlight COVID-19 Risks

Collaboration aims to raise awareness about COVID-19 dangers.

Corporate DealsFeb 4, 2025 · 6:59pm ET

IVVDInvivyd, Inc.+87.2%

Invivyd Partners with Jim Harbaugh to Highlight COVID-19 Risks

Corporate DealsJan 6, 2025 · 7:01am ET

GDTCCytoMed Therapeutics Ltd

CytoMed Therapeutics Signs Collaboration Agreement with SunAct Cancer Institute for Phase 2 Clinical Trial

Agreement aims to advance treatment of solid cancers using Gamma Delta T Cells.

Corporate DealsJan 6, 2025 · 7:01am ET

GDTCCytoMed Therapeutics Ltd+127.2%

CytoMed Therapeutics Signs Collaboration Agreement with SunAct Cancer Institute for Phase 2 Clinical Trial

1
…
32
33

Next →

RVOL

12.7x

Max high

$0.58

Fuel

1h 57m

RVOL

12.4x

Max high

$2.34

Fuel

12h 3m

RVOL

14.2x

Max high

$7.93

Fuel

9m